Weekly cabazitaxel in "unfit" metastatic castration-resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment: Preliminary results of CABASEM-SOGUG phase II trial.

Anido Herranz, Urbano; Fernández Calvo, Ovidio

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/783

ISSN: 0732-183X

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

Journal Of Clinical Oncology

Type of content

Publicación de congreso